Please login to the form below

Not currently logged in
Email:
Password:

Venclyxto

This page shows the latest Venclyxto news and features for those working in and with pharma, biotech and healthcare.

Venclexta plus Gazyva approval adds to non-chemo options in CLL

Venclexta plus Gazyva approval adds to non-chemo options in CLL

Venclexta (Venclyxto outside the US) is co-marketed by AbbVie and Roche and the combination with Gazyva in first line treatment of CLL could see its use expanded greatly. ... against Venclexta (Venclyxto).

Latest news

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics